Loading...
dock_to_right dock_to_right arrow_back

Terminology chevron_right Concepts chevron_right 1208691004

Production
add
1208691004
The component that hold information about this concept.
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug)
Alogliptin (as alogliptin benzoate) 25 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet
900000000000073002 |Sufficiently defined by necessary conditions definition status (core metadata concept)|
Specifies if the concept version is primitive or defined. Set to a descendant of 900000000000444006

Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug)

SCTID: 1208691004, Defined, Active


1208691004|Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug)|
  • en Alogliptin (as alogliptin benzoate) 25 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet
  • en Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug)

1208691004 |Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug)|

=== 421026006 |Conventional release oral tablet (dose form)| +
    732936001 |Tablet (unit of presentation)| +
    1208689007 |Product containing only alogliptin and pioglitazone in oral dose form (medicinal product form)| :
        { 732943007 |Has basis of strength substance (attribute)| = 395828009 |Pioglitazone (substance)|,
          762949000 |Has precise active ingredient (attribute)| = 116097005 |Pioglitazone hydrochloride (substance)|,
          732947008 |Has presentation strength denominator unit (attribute)| = 732936001 |Tablet (unit of presentation)|,
          732945000 |Has presentation strength numerator unit (attribute)| = 258684004 |Milligram (qualifier value)| }
        { 732943007 |Has basis of strength substance (attribute)| = 702799001 |Alogliptin (substance)|,
          762949000 |Has precise active ingredient (attribute)| = 702800002 |Alogliptin benzoate (substance)|,
          732947008 |Has presentation strength denominator unit (attribute)| = 732936001 |Tablet (unit of presentation)|,
          732945000 |Has presentation strength numerator unit (attribute)| = 258684004 |Milligram (qualifier value)| }
Active

4970522015 - Alogliptin (as alogliptin benzoate) 25 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet (en) View

4970522015
en
Synonym (core metadata concept)
Alogliptin (as alogliptin benzoate) 25 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet
900000000000448009 |Entire term case insensitive (core metadata concept)|
Preferred
True

4970521010 - Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) (en) View

4970521010
en
Fully specified name (core metadata concept)
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug)
900000000000448009 |Entire term case insensitive (core metadata concept)|
Preferred
True

Relationship (15099702020) - 1208691004 -> 1208689007 (116680003) View

116680003 |Is a (attribute)|
1208689007 |Product containing only alogliptin and pioglitazone in oral dose form (medicinal product form)|
0
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15099703026) - 1208691004 -> 421026006 (411116001) View

411116001 |Has dose form (attribute)|
421026006 |Conventional release oral tablet (dose form)|
0
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15099704021) - 1208691004 -> 732936001 (763032000) View

763032000 |Has unit of presentation (attribute)|
732936001 |Tablet (unit of presentation)|
0
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15099706023) - 1208691004 -> 116097005 (762949000) View

762949000 |Has precise active ingredient (attribute)|
116097005 |Pioglitazone hydrochloride (substance)|
1
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15099707025) - 1208691004 -> 395828009 (732943007) View

732943007 |Has basis of strength substance (attribute)|
395828009 |Pioglitazone (substance)|
1
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15099709027) - 1208691004 -> 258684004 (732945000) View

732945000 |Has presentation strength numerator unit (attribute)|
258684004 |Milligram (qualifier value)|
1
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15099711020) - 1208691004 -> 732936001 (732947008) View

732947008 |Has presentation strength denominator unit (attribute)|
732936001 |Tablet (unit of presentation)|
1
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15099712029) - 1208691004 -> 702800002 (762949000) View

762949000 |Has precise active ingredient (attribute)|
702800002 |Alogliptin benzoate (substance)|
2
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15099713023) - 1208691004 -> 702799001 (732943007) View

732943007 |Has basis of strength substance (attribute)|
702799001 |Alogliptin (substance)|
2
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15099715027) - 1208691004 -> 258684004 (732945000) View

732945000 |Has presentation strength numerator unit (attribute)|
258684004 |Milligram (qualifier value)|
2
900000000000011006 |Inferred relationship (core metadata concept)|
True

Relationship (15099717024) - 1208691004 -> 732936001 (732947008) View

732947008 |Has presentation strength denominator unit (attribute)|
732936001 |Tablet (unit of presentation)|
2
900000000000011006 |Inferred relationship (core metadata concept)|
True

1208689007 View

1208689007
Product containing only alogliptin and pioglitazone in oral dose form (medicinal product form)
Alogliptin and pioglitazone only product in oral dose form
900000000000073002 |Sufficiently defined by necessary conditions definition status (core metadata concept)|
True

421026006 View

421026006
Conventional release oral tablet (dose form)
Oral tablet
900000000000073002 |Sufficiently defined by necessary conditions definition status (core metadata concept)|
True

732936001 View

732936001
Tablet (unit of presentation)
Tablet
900000000000074008 |Necessary but not sufficient concept definition status (core metadata concept)|
True
esc